Daohong Zhou, M.D., a professor of pharmacodynamics and The Henry E. Innes Professorship of Cancer Research, and Guangrong Zheng, Ph.D., an associate professor of medicinal chemistry, have been awarded a R56 grant from the National Institutes of Health.
The grant entitled, “Identifying Novel Senolytic Agents and Molecular Targets,” will help to develop novel senolytic agents and identify molecular targets that are important for survival of senescent cells.